DABRA laser system achieved 94% success rate in patients with peripheral artery disease

Ra Medical Systems announced study results for DABRA (Destruction of Arteriosclerotic Blockages by laser Radiation Ablation) a novel, minimally invasive excimer laser system that non-thermally, photochemically ablates channels in vascular blockages. Unlike many treatments for PAD that may damage the arterial wall, DABRA treats blockages with minimal vascular trauma. The study demonstrated a 94% success rate treating peripheral artery disease (PAD) by ablating arterial blockages. In the study, 292 lesions were treated in 200 patients at an outpatient office-based lab in El Centro, Calif., an area with high diabetes, peripheral artery disease, and amputation rates.

DABRA delivered results rapidly and safely and can treat all types of plaques in arteries above and below the knee. Patients are discharged in two to three hours, allowing them to quickly return to their daily lives. Most importantly, DABRA meets the need for safe, high-quality tools in smaller-scale settings so reducing costs. Findings were presented at this year’s Joint Interventional Meeting.